We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

Play the video to learn more
The same is true in terms of the factors that you can use to identify or select a specific treatment or a specific target for that treatment. Again, let’s take, for instance, the first column here, which refers to the importance of hypoglycaemia in selecting a treatment for a person with type 2 diabetes. Now, you can see that one diabetologist believes that this is important enough to rank the risk of hypoglycaemia in second place. But another diabetologist is less concerned about the risk of hypoglycaemia, to the extent that they only rank hypoglycaemia in sixth place. So, what I’m trying to convey here is that, while it’s important that we have factors that help us to gain a better description of an individual’s phenotype, and because of that we may have a better chance of identifying specific treatment, the way these factors are interpreted is largely based on the personal experience of every one of us.
Select image for larger view

Cahn A, Raz I, Kleinman Y, Balicer R, Hoshen M, Lieberman N, Brenig N, Del Prato S, Cefalu WT. Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists. Diabetes Care. 2015 Dec;38(12):2293-300.
http://www.ncbi.nlm.nih.gov/pubmed/26519337